Cargando…
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity
BACKGROUND: Breast cancer is the most prevalent tumor entity in Li-Fraumeni syndrome. Up to 80% of individuals with a Li-Fraumeni-like phenotype do not harbor detectable causative germline TP53 variants. Yet, no systematic panel analyses for a wide range of cancer predisposition genes have been cond...
Autores principales: | Penkert, Judith, Schmidt, Gunnar, Hofmann, Winfried, Schubert, Stephanie, Schieck, Maximilian, Auber, Bernd, Ripperger, Tim, Hackmann, Karl, Sturm, Marc, Prokisch, Holger, Hille-Betz, Ursula, Mark, Dorothea, Illig, Thomas, Schlegelberger, Brigitte, Steinemann, Doris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081832/ https://www.ncbi.nlm.nih.gov/pubmed/30086788 http://dx.doi.org/10.1186/s13058-018-1011-1 |
Ejemplares similares
-
GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families
por: Schubert, Stephanie, et al.
Publicado: (2017) -
On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
por: Penkert, Judith, et al.
Publicado: (2016) -
Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence
por: Penkert, Judith, et al.
Publicado: (2021) -
Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li–Fraumeni syndrome
por: Winter, Greta, et al.
Publicado: (2021) -
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)